.After antibody-drug conjugate (ADC) expert Seagen was actually marketed to Pfizer in 2013 for an en...
.On the heels of a stage 3 win that fell short to thrill entrepreneurs, Ironwood Pharmaceuticals is ...
.Don't cease Monte Rosa Therapeutics now. The Boston-based biotech is actually enjoying after signin...
.Welcome to this week's Chutes & Ladders, our roundup of considerable management hirings, shootin...
.Commemorating his firm's upsized going public (IPO), Septerna CEO Jeffrey Finer called the position...
.AbbVie has actually come back to the resource of its antipsychotic giant Vraylar trying to find an ...
.GenSight Biologics is actually full weeks out of losing amount of money. Once more. The biotech onl...
.Monopar Therapies is bouncing back a medicine from the scrap heap of AstraZeneca's uncommon disease...
.Along with new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of profess...
.After forming a gene therapy collaboration with Dyno Therapies in 2020, Roche is actually back for ...